Absence of signs of melanoma (tenderness, jaundice, localized neurologic signs such as weakness, or any other sign suggesting systemic spread) or absence of symptoms of melanoma (cough, dyspnea, pain, paresthesia, or any other symptom suggesting the po...
HCPCS code
Name of the Procedure:
Absence of signs of melanoma
Common names: Melanoma Screening, Melanoma Evaluation
Technical/Medical terms: Absence of systemic signs of melanoma (G8749), Melanoma Surveillance
Summary
This procedure involves an assessment to ensure that a patient shows no signs or symptoms indicating the presence or spread of melanoma, a type of skin cancer. It's part of routine melanoma surveillance to detect any potential issues early.
Purpose
This procedure is focused on identifying any indications of melanoma or its spread in patients who have a history of melanoma or are at high risk. The primary goals are to catch melanoma early when it is most treatable and prevent it from progressing to a more severe stage.
Indications
- History of melanoma
- High-risk individuals (e.g., those with numerous moles, family history of skin cancer)
- Presence of symptoms like unexplained cough, dyspnea, localized neurologic signs (e.g., weakness), or jaundice
- Routine follow-up for melanoma survivors
Preparation
- No specific preparation is generally required for a basic physical examination.
- Patients may need to provide a detailed medical and family history.
- Previous diagnostic imaging or biopsy results may be reviewed.
Procedure Description
- Initial Consultation: The healthcare provider will review the patient's history and discuss any new symptoms.
- Physical Examination: The provider will thoroughly examine the skin for any new or changing moles or lesions.
- Systematic Assessment: The provider will check for systemic signs of melanoma, such as tenderness, jaundice, localized neurologic signs like weakness, or respiratory symptoms indicative of spread.
- Documentation: Findings will be recorded and compared with previous assessments to monitor changes over time.
Duration
The procedure typically takes between 15 to 30 minutes.
Setting
This assessment is usually performed in an outpatient setting, such as a dermatologist's office or a specialized skin cancer clinic.
Personnel
- Dermatologist or Primary Care Physician
- Nurse or Medical Assistant
Risks and Complications
- Misdiagnosis or overlooking early signs
- Unnecessary anxiety if benign lesions are mistaken for melanoma
- Rarely, allergic reactions to any topical agents used during the examination
Benefits
- Early detection of melanoma, leading to timely and effective treatment
- Peace of mind for patients with no signs of melanoma
- Ongoing surveillance helps in managing and monitoring skin health
Recovery
- There is no recovery period since the procedure is non-invasive.
- Patients may be advised on skin self-checks and provided with educational materials.
- Routine follow-up appointments are usually scheduled, particularly for high-risk patients.
Alternatives
- Dermatoscopic Evaluation: Use of a dermatoscope for a more detailed inspection of moles.
- Biopsy: If suspicious lesions are found, a biopsy can be performed.
- Imaging Studies: For patients exhibiting systemic symptoms, imaging studies like CT or PET scans may be ordered.
Patient Experience
During the procedure, the patient may feel minor discomfort during a thorough skin examination but should not experience pain. Post-procedure, patients are generally able to resume normal activities immediately. If a skin sample is taken for biopsy, minor soreness might be felt at the sampling site.